Ategrity Specialty Insurance (ASIC)
Underwrites E&S coverage for U.S. small-business and middle-market commercial risks.
Something off on this page? Send us feedback.
Underwrites excess-and-surplus insurance for small and medium-sized U.S. businesses through wholesale brokers and surplus-lines agents. Coverage spans casualty, commercial property, management liability, professional liability, allied healthcare, and architects-and-engineers E&O, with a single operating segment built around technology-enabled underwriting.
Underwrites excess-and-surplus property-and-casualty coverage for small and medium-sized U.S. businesses. Product lines include general liability, commercial property, management liability, miscellaneous professional liability, allied healthcare, and architects-and-engineers E&O, with casualty and property forming the core underwriting mix.
Sells exclusively through licensed surplus-lines brokers and wholesale agents, using brokerage and small-business channels. The platform emphasizes productionized underwriting: micro-segmentation, centralized underwriting governance, data analytics, and automated workflows for high-volume submissions.
Operations are concentrated in the United States and reported as one E&S insurance segment. Distribution relationships, underwriting discipline, claims handling, financial-strength ratings, and the regulatory treatment of non-admitted insurance shape the business.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Jul 7, 2026 | Barclays | Reiterate | Rating: —Target: $26 | Target: $28 |
| Feb 26, 2026 | Citigroup | Downgrade | ||
| Feb 20, 2026 | Barclays | Reiterate | Rating: —Target: $25 | Target: $26 |
| Jan 13, 2026 | Wells Fargo | Reiterate | Rating: —Target: $23 | Target: $25 |
| Jan 8, 2026 | Barclays | Reiterate | Rating: —Target: — | Target: $25 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $644.6M · Total debt $1.8M · Total assets $1.40B · Shareholders' equity $664.4M
- Revenue
- $148.5M
- Operating income
- $46.4M
- Net income
- $33.5M
No dividends on record.
| Institutions | 11.50% | 5.52M shares | |
|---|---|---|---|
| 88 holders · as of Jun 30, 2026 | |||
| Insiders | 80.75% | 38.79M shares | |
| 10 holders · as of Jul 20, 2026 | |||
| Other | 7.75% | 3.72M shares | |
| remainder | |||
48.03M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Stuart J. ZimmerInsiderdirector, 10 percent owner | 80.23% | 38.54M | filed Oct 1, 2025 |
Nuveen, LLCInstitution | 1.51% | 724,481 | as of Jun 30, 2026 |
BlackRock, Inc.Institution | 1.28% | 614,785 | as of Jun 30, 2026 |
T. Rowe Price Investment Management, Inc.Institution | 1.19% | 573,199 | as of Jun 30, 2026 |
Cannell Capital LLCInstitution | 1.02% | 490,482 | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| May 4, 2026 | Chris Schenk | officer: See Remarks | +2,500 | $19.99 |
| Oct 27, 2025 | Justin G. Cohen | director, officer: Chief Executive Officer | +5,200 | $19.41 |
| Sep 29, 2025 | Stuart J. Zimmer | director, 10 percent owner: | +6,130 | $19.37 |
| Sep 30, 2025 | Stuart J. Zimmer | director, 10 percent owner: | +5,000 | $19.47 |
| Sep 25, 2025 | Stuart J. Zimmer | director, 10 percent owner: | +4,179 | $19.45 |
- Kinsale Capital Group
Pure-play E&S insurer overlapping in casualty, property, and SMB risks
- W. R. Berkley
Large commercial P&C group with multiple U.S. E&S platforms
- Markel Group
Global specialty insurer with U.S. wholesale E&S overlap
- RLI
Specialty P&C writer active in E&S casualty and property
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Ategrity Specialty Insurance | $26.55 | −1.74% | $1.30B | 12.6 | 11.6 | 2.5 | +23.4% |
| Kinsale Capital Group | $347.48 | −1.24% | $8.01B | 14.3 | 16.5 | 4.0 | −3.7% |
| W. R. Berkley | $68.17 | 0.00% | $25.38B | 14.0 | 14.4 | 1.4 | +1.2% |
| Markel Group | $1,764.57 | +0.07% | $21.85B | 9.7 | 15.4 | 1.3 | +17.6% |
| RLI | $57.78 | −0.61% | $5.33B | 12.2 | 21.4 | 2.7 | +16.0% |
| Median | 13.1 | 16.0 | 2.1 | +8.6% |